Clinical Trial

Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome

Study acronym: EPIHEAR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this case-control study is to pave the way for new revolutionary treatment measures within hearing loss that could either replace or delay the need for hearing aids. The study focuses on people with Turner syndrome (TS). The aim is to find out if there are specific DNA methylation patterns and/or RNA expression profiles linked to sensorineural hearing loss (SNHL) in people with TS. Additionally, the structure and function of the inner ear in these individuals will be examined to see if there is a connection to their epigenetic profile. The main question it aims to answer is: Does epigenetics constitute a common denominator for some of the unexplained SNHL cases? Turner Syndrome (TS) represents an ideal model for studying epigenetics related to sensorineural hearing loss (SNHL). Participants will undergo the following tests: * Ear examinations * Hearing tests * Balance tests * Blood tests * MRI scans * CBCT (cone-beam computed tomography) scans
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-16; most recent amendment 2026-01-24.
Status change: Not Yet Recruiting → Recruiting 2025-04-25
Trial Details
NCT Number NCT06507007
Lead Sponsor Gødstrup Hospital
Collaborators: University of Aarhus, Aarhus University Hospital
Conditions Sensorineural Hearing Loss, Turner Syndrome, Inner Ear Disease
Enrollment 150 participants
Start Date 2025-02-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-27